Watson-Marlow Builds Cased Pumps for Biotechnology

Developed for biotechnology applications, WMFTS’ range of peristaltic pumps offers an industry-leading solution to fluid handling challenges.

Backed by a global network of technical and support teams, WMFTS is an established fluid processing and handling partner. Its portfolio of peristaltic cased pumps is scalable and developed to optimise the performance of your processing for a wide variety of biopharmaceutical applications that demand sterility, repeatability, flexibility and precision.

To further optimise your process, the 500, 600 and 700 series Watson-Marlow cased pumps are both EtherNet/IP and PROFINET enabled for digital network control to reduce operating costs and minimise downtime. With network dispensing functions, operators can create dispensing and dosing recipes which can be remotely adjusted and controlled to ensure accurate and repeatable filling.

The direct interface provides an extended, smart communication capability that enables seamless integration with pressure and flow sensors to safeguard process integrity.

About Watson-Marlow Fluid Technology Solutions

Watson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in manufacturing niche peristaltic pumps and associated fluid path technologies for the life sciences and process industries. WMFTS is a wholly owned subsidiary of Spirax-Sarco Engineering plc and is headquartered in Cornwall, England, with operations in 43 countries. Further information can be found at www.wmfts.com.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!

Sign up now!

  • <<
  • >>

Join the Discussion